Join to access to all OVN content. Join for Free

Results for 'drug development'

How and Why MSLs Bring VALUE to an Organization
Partner Avatar MSL Talk: Tom Caravela, Steven Stein
How and Why MSLs Bring VALUE to an Organization

MSL role, KOL engagement, drug development process, enhancing medical affairs, strategic direction MSL

In this episode, Steven Stein, senior director of global field medical at Arena Pharmaceuticals, joins the discussion to explore the evolving role of MSLs. He delves into the concept of value within the MSL role and the strategic timing for their involvement in the drug development process. Ste…

Dec 14th • 31 mins listen

Is it Ever Too Early or Too Late
Partner Avatar MSL Talk: Tom Caravela, Jeff Vaughn, Dean McAllister
Is it Ever Too Early or Too Late

Medical Science Liaison, drug development, early MSL engagement, clinical trial planning, strategic prioritization

In this episode, Tom Caravela is joined by Jeff Vaughn and Dean McAllister to discuss the critical timing of Medical Science Liaison (MSL) involvement in drug development. They explore misconceptions and historical approaches, highlighting the impact and internal value of early MSL engagement. The c…

Feb 18th • 34 mins listen

Oncology Clinical Trials and Drug Development
OVN Avatar The Oncology Nursing Podcast
Oncology Clinical Trials and Drug Development

ONS member Moe Schwartz, PharmD, BCOP, professor of pharmacy practice in the James L. Winkle College of Pharmacy at the University of Cincinnati in Ohio and member of the Cincinnati Tri-State ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss cancer drug…

Oct 16th • 38 mins listen

Related Topics

Loading...